Plectin drives hepatocellular carcinoma progression and metastasis through cytoskeletal reorganization and oncogenic signaling, making it a promising therapeutic target for overcoming therapy ...

Doctors aren't sure exactly what causes all cases of hepatocellular carcinoma, but they've identified some things that may increase your risk for getting it: Hepatitis B or hepatitis C.

Globally, more than 30% of the adult population has metabolic dysfunction-associated steatotic liver disease (MASLD). People ...

New research reveals distinct epidemiological trends in liver cancer across Mexico, with gender and regional variations ...

Transplantation combined with immunotherapy to cure liver cancer. Hepatocellular carcinoma (HCC) is the most common type of liver cancer in Switzerland and worldwide. Immunotherap ...

SGLT-2 inhibitors vs DPP-4 inhibitors were associated with a reduced risk for liver cirrhosis among patients with type 2 diabetes.

Having cirrhosis increases your risk of getting liver cancer (hepatocellular carcinoma or HCC ... In these conditions fat builds up in the liver. The fat causes inflammation and damage, which might ...

Eating vegetables can help reduce the risk of liver cancer by 65 per cent, according to a study. The study, led by researchers from the INSERM, the French National Institute of Health and Medical ...

Almost one in three adults worldwide suffers from fatty liver disease, also known as metabolic dysfunction-associated fatty liver disease (MASLD). MASLD can lead to serious liver diseases such as ...

Hepatocellular carcinoma is a leading cause of cancer-related death globally. The treatment of hepatocellular carcinoma is ...